当前位置: 首页 > 期刊 > 《中国医学创新》 > 20202
编号:13516742
微波消融治疗合并肝硬化小肝癌患者的无瘤生存影响因素分析(4)
http://www.100md.com 2020年1月15日 《中国医学创新》 20202
     [13] Ierardi A M,Giorlando F,Piacentino F,et al.Factors predicting outcomes of microwave ablation of small hepatocellular carcinoma[J].Radiol Med,2017,122(2):81-87.

    [14]肖蓉,田虹,胡晓丹,等.微波消融治疗老年原发性肝癌患者的无瘤生存影响因素分析[J].河北医药,2018,40(2):277-279,284.

    [15] Kim W,Cho S K,Shin S W,et al.Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy[J].Abdom Radiol(NY),2019,44(6):2283-2292.

    [16]严文韬,邢昊,王明达,等.肝癌术后复发的治疗选择[J/OL].中华肝脏外科手术学电子杂志,2019,8(5):396-399.

    [17]廖凌峰,薛建章,李士坤.经皮微波消融术治疗合并肝硬化的原发性小肝癌患者生存分析[J].实用肝脏病杂志,2018,21(2):257-260.

    [18] Gong Q,Qin Z,Hou F.Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation[J].Oncol Lett,2017,14(6):7045-7048.

    [19]邬德东,史继静,张倩,等.索拉非尼联合三氧化二砷治疗晚期原发性肝癌的临床研究[J].现代肿瘤医学,2019,27(15):2728-2731.

    [20]方阳阳,荆洪英.紫杉醇联合索拉非尼治疗原发性肝癌的临床观察[J].中国医学创新,2019,16(23):68-71.

    [21] Yan S Y,Zhang Y,Sun C,et al.The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinoma[J].Oncol Lett,2016,13(12):951-955.

    (收稿日期:2019-10-22) (本文編辑:张爽)

    ①辽宁省盘锦辽油宝石花医院 辽宁 盘锦 124010

    通信作者:刘芳, http://www.100md.com(刘芳 陈强 陈灿)
上一页1 2 3 4